Needham & Company LLC restated their hold rating on shares of UiPath (NYSE:PATH - Free Report) in a research note issued to investors on Thursday morning,Benzinga reports.
A number of other research analysts have also recently weighed in on the stock. Evercore ISI boosted their target price on shares of UiPath from $13.00 to $16.00 and gave the company an "in-line" rating in a research note on Friday, September 6th. Wells Fargo & Company reduced their price objective on UiPath from $15.00 to $13.00 and set an "equal weight" rating for the company in a report on Wednesday, October 23rd. BMO Capital Markets boosted their price objective on UiPath from $15.00 to $16.00 and gave the company a "market perform" rating in a research note on Friday, December 6th. JPMorgan Chase & Co. lifted their target price on shares of UiPath from $17.00 to $18.00 and gave the stock an "overweight" rating in a research note on Friday, December 6th. Finally, UBS Group started coverage on shares of UiPath in a research note on Thursday, December 12th. They set a "sell" rating and a $14.00 price target on the stock. One research analyst has rated the stock with a sell rating, sixteen have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and a consensus price target of $17.50.
Get Our Latest Stock Report on PATH
UiPath Stock Down 1.8 %
UiPath stock traded down $0.23 during mid-day trading on Thursday, reaching $12.74. 10,210,415 shares of the company's stock were exchanged, compared to its average volume of 9,675,471. The business's fifty day simple moving average is $13.41 and its 200 day simple moving average is $12.61. UiPath has a one year low of $10.37 and a one year high of $27.87. The firm has a market capitalization of $7.00 billion, a PE ratio of -79.63 and a beta of 0.94.
Institutional Trading of UiPath
A number of hedge funds have recently made changes to their positions in PATH. Future Financial Wealth Managment LLC purchased a new position in UiPath during the third quarter valued at $26,000. JTC Employer Solutions Trustee Ltd bought a new position in UiPath in the 3rd quarter worth about $26,000. Hantz Financial Services Inc. purchased a new stake in UiPath during the 2nd quarter valued at about $28,000. Quarry LP increased its stake in UiPath by 654.4% during the 3rd quarter. Quarry LP now owns 3,146 shares of the company's stock valued at $40,000 after purchasing an additional 2,729 shares in the last quarter. Finally, Redwood Wealth Management Group LLC purchased a new position in UiPath in the second quarter worth about $43,000. 62.50% of the stock is owned by institutional investors.
UiPath Company Profile
(
Get Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Further Reading
Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.